Navigation Links
BioElectronics Corporation Announces New Website for Italian Market


FREDERICK, Md., April 29 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced a new website, is now selling the ActiPatch products to the Italian market. TSS Medical, (Tecnica Scientifica Service), designed the site to reach both pharmacies and consumers in Italy. TSS Medical is a medical provider and distributor to Italy's retail pharmacies and is headquartered in Torino, Italy. Over 10,000 ActiPatch units were acquired by TSS Medical to initiate the retail product launch.

ActiPatch is a wafer thin patch with a microcurrent that has been shown to reduce pain and swelling and accelerate healing with no known side effects. The science behind ActiPatch is well-proven and has been successfully used as an office based therapy for many years. BioElectronics Corporation, through it's ActiPatch product, makes this technology available for use in any setting in an easy to wear patch that is placed directly over the soft tissue injury or surgical incision. ActiPatch is drug-free, simple to use and in most cases relieves pain and swelling very quickly. ActiPatch may also be a cost-effective alternative to OTC and prescription medications. Physicians are so impressed with the power of the patch that they are recommending ActiPatch for surgical recovery, sports injuries and other of aches, pains and soft tissue injuries.

Alessio Petricca, Head of Marketing and Operations of TSS Medical explains, "TSS Medical has had an exceptional response to the ActiPatch products, both at the ESRA Congress in Salerno and at the Congress of Chronic Pain in Genoa. The market potential for this innovative, drug-free therapy is enormous." The new website, provides an informative, easy to use sales channel for the ActiPatch products. Petricca promises that enhancements to the beautifully designed site are coming in the near future.

"We are watching the success of TSS Medical and their new website with great excitement," says Andrew Whelan, CEO of Bioelectronics Corporation. "This may be the beginning of our products becoming a worldwide choice for a drug free, cost-effective treatment for pain and swelling," adds Whelan.

About TSS Medical:

TSS Medical was established in 1998 and employs 40 sales agents. TSS is headquartered in Torino, Italy and maintains ISO 9000 TUV certification. The company distributes medications and medical devices for postoperative recovery and chronic pain for such leading companies as On Q, Vertis PNT, Anodyne Therapy and others.

For more information visit

About BioElectronics:

BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

Contact: Patricia Baker


SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond
2. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
3. BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11
4. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
5. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
6. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
7. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
8. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
9. Torchmark Corporation Declares Dividend
10. Steris Corporation Announces the Appointment of Two New Directors
11. Digirad Corporation Reports Financial Results for First-Quarter 2008
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: